What is Bickett Genetics?
Based in northwest Georgia, Bickett Genetics operates as a specialized provider of bovine embryo transfer services, offering a comprehensive suite of solutions including in vitro fertilization (IVF), on-farm embryo transfer, and herd health management. As an AETA-certified and USDA-approved entity for EU exports, the company bridges the gap between high-level scientific research and practical livestock management. Under the leadership of Dr. Todd J. Bickett, the firm utilizes cutting-edge reproductive technologies to enhance cattle genetics, serving a diverse client base that demands precision and regulatory compliance in their breeding programs. The company's market position is defined by its technical rigor and its ability to facilitate international trade through its certified export capabilities.
How much funding has Bickett Genetics raised?
Bickett Genetics has raised a total of $22K across 1 funding round:
Debt
$22K
Debt (2021): $22K with participation from PPP
Key Investors in Bickett Genetics
PPP
Public-Private Partnership
What's next for Bickett Genetics?
With the recent influx of capital, Bickett Genetics is poised to accelerate its operational footprint and technological capabilities. The strategic roadmap likely involves expanding its in-clinic IVF infrastructure and deepening its reach within the regional livestock market. As the firm transitions through its current growth phase, the focus will remain on maintaining its high-standard certification status while scaling its service delivery model to meet the increasing demand for superior bovine genetics. Investors are closely monitoring how this infusion of resources will translate into broader market penetration and the potential for further international expansion, given the company's existing regulatory approvals for global trade.
See full Bickett Genetics company page
